Lung; Node
21
5
6
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
4.8%
1 terminated out of 21 trials
85.7%
-0.8% vs benchmark
0%
0 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (21)
Using e-Nose Technology to Identify Early Lung Cancer
Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
Thin EBUS Pilot Study
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
Intra-operative Air Leak Management After Minimally Invasive Lung Segmental Resection
CBCT-Guided Navigational Bronchoscopy For Lung Nodules
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
From Benchmark to Surgical Activity: the Role of Endobronchial Fiducial Markers for Ground Glass Lung Nodules Resection.
Diagnosis of Peripheral Lung Nodules Using Cryobiopsy
Diagnostic Yeld of Ultrathin Bronchoscopy in Peripheral Pulmonary Lesions
Investigating Incidental Pulmonary Nodules in Underserved Communities
Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During EBUS-TBNA
Prospective rAndomized sTudy efficaCy tHree-dimensional rEconstructions Segmentectomy
Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
The Early Diagnosis of Pulmonary Nodule Based on Multi-dimension Messages
Preoperative Computed Tomography-guided Localization for Lung Nodules: Localization Needle Versus Coil
Low-dose Computed Tomography-guided Core Needle Biopsy for Lung Nodules
Airway Navigation Database Asia for Diagnosis of Peripheral Pulmonary Nodules
Clinical Performance Evaluation of Veye Lung Nodules